HIV News and Research

RSS

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

"Global efforts to reach the 'three zeros' for women and girls -- zero new HIV infections, zero discrimination and zero AIDS-related deaths -- are gaining momentum," Michelle Bachelet, executive director of U.N. Women, Michel Sidibe, executive director of UNAIDS, and Jennifer Gatsi Mallet, executive director of the Namibia Women's Health Network, write in an Inter Press Service opinion piece.

13 Dec 2012

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).

13 Dec 2012

BBC News examines HIV microbicide research

BBC News examines ongoing efforts to develop a female-controlled microbicide to prevent HIV infection. But so far, "efforts ... have presented a great deal of frustration in the fight against this global epidemic," the news service writes, detailing the history of some failed experiments.

12 Dec 2012

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis (TB), including patients with HIV co-infection.

12 Dec 2012

Uganda's proposed anti-homosexuality legislation would inhibit health care access

The Center for Global Health Policy's "Science Speaks" blog examines the potential impacts of a proposed anti-homosexuality bill in Uganda, writing that the bill "would stand as an obstacle to both access to health care and to the ability of health care providers to even offer services," making prevention of "the bill's passage a matter of life and death, as well as of rights and dignity."

12 Dec 2012

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme.

12 Dec 2012

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

A clinical trial will examine an investigational drug's early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis.

12 Dec 2012

Janssen announces U.S. prescribing information update for EDURANT tablets

Janssen Therapeutics, Division of Janssen Products, LP, announced today that the U.S. Food and Drug Administration (FDA) has approved a prescribing information update for EDURANT (rilpivirine) tablets to include 96-week pooled data from the Phase 3 ECHO and THRIVE studies, which evaluated the efficacy and safety of EDURANT for the treatment of human immunodeficiency virus type 1 (HIV-1) in antiretroviral treatment-naive adults.

11 Dec 2012

Recognizing reproductive rights as human rights

Noting the recognition of International Human Rights Day on December 9, Purnima Mane, president and CEO of Pathfinder International, writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, "Every person should be able to make decisions about her or his body," making reproductive rights a human rights issue.

11 Dec 2012

GlobalPost series examines HIV/AIDS in European, MENA regions

As part of its ongoing series, titled "The State of AIDS," GlobalPost published two articles examining the epidemic in different regions. In Eastern Europe, rates of HIV/AIDS diagnoses have risen in several countries, including Ukraine and Russia, according to the first article, which discusses some of the potential reasons for the increases.

11 Dec 2012

PEPFAR blueprint relies on science to inform policies, SciDev.Net reports

"Science is at the center of efforts to design and implement more effective preventative and care programs for HIV/AIDS set out in a blueprint published by a U.S. government initiative that fights the disease," SciDev.Net reports, referencing the PEPFAR Blueprint: Creating an AIDS-free Generation that was released November 29.

11 Dec 2012

New hope for leukemia patients

Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania

10 Dec 2012

IQWiG investigates benefits of rilpivirine for HIV treatment

Since the start of 2012, a new drug called rilpivirine has been available for adult patients infected with the human immunodeficiency virus type 1 (HIV-1). It is marketed by two different pharmaceutical companies, by one as a single agent (trade name Edurant-) and by the other as a fixed combination with other HIV drugs (trade name Eviplera-).

8 Dec 2012

International community should 'not forget' importance of treatment, care for children with HIV

The "progress and momentum" behind stopping mother-to-child HIV transmission is "reason to celebrate," Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, and Peter Twyman, CEO of Keep a Child Alive, write in The Hill's "Congress Blog."

8 Dec 2012

Lancet editorial examines possibility of 'AIDS-free generation,' PEPFAR blueprint

"After three decades of global emergency responses and a series of scientific breakthroughs in the fight against HIV/AIDS, it is now tempting to ask if we are marching towards the end of AIDS," an editorial in the Lancet states.

8 Dec 2012

GlobalPost blog interviews reporter Joanne Silberner about PRI series on cancer in developing world

GlobalPost's "Global Pulse" blog features an interview with freelance reporter and artist-in-residence at the University of Washington in Seattle Joanne Silberner, a former NPR correspondent, about her recent series for PRI's "The World," titled "Cancer's New Battleground -- The Developing World."

8 Dec 2012

Cost-benefit analysis of TasP compared with circumcision, ART

In a study published online in the Proceedings of the National Academy of Sciences, Till Barnighausen, David Bloom, and Salal Humair of the Harvard School of Public Health examine "whether [HIV treatment as prevention (TasP)] is indeed a game changer or if comparable benefits are obtainable at similar or lower cost by increasing coverage of medical male circumcision (MMC) and antiretroviral treatment (ART)."

8 Dec 2012

Boehner, Obama move to direct talks on budget

As the negotiations shift to the president and House speaker, some Republicans appear to be encouraging their colleagues to abandon staunch opposition to any tax rate hike, The Washington Post reports. But several outlets note that little movement is apparent from either side.

7 Dec 2012

GlobalPost reports on HIV/AIDS in Latin America

In its continuing series titled "The State of AIDS," GlobalPost examines the HIV/AIDS epidemic in Latin America and the Caribbean, where "[m]ajor gains have been made in the fight against the spread of HIV" over the past decade, particularly in stopping mother-to-child transmission (MTCT).

7 Dec 2012

Ultrasound applied to fingertips can stimulate sensory pathways leading to the brain

A century after the world's first ultrasonic detection device - invented in response to the sinking of the Titanic -Virginia Tech Carilion Research Institute scientists have provided the first neurophysiological evidence for something that researchers have long suspected: ultrasound applied to the periphery, such as the fingertips, can stimulate different sensory pathways leading to the brain.

7 Dec 2012

HIV News and Research

HIV/AIDS efforts among women, girls gaining momentum, but journey 'far from over'

Patients with multiple sclerosis have low levels of Egr2/3 protein in T lymphocytes

BBC News examines HIV microbicide research

AstraZeneca, Case Western Reserve initiate AZD5847 Phase 2a trial in TB

Uganda's proposed anti-homosexuality legislation would inhibit health care access

Drugs for Neglected Diseases receives UNITAID grant for paediatric HIV programme

Clinical trial to examine AstraZeneca experimental drug against pulmonary tuberculosis

Janssen announces U.S. prescribing information update for EDURANT tablets

Recognizing reproductive rights as human rights

GlobalPost series examines HIV/AIDS in European, MENA regions

PEPFAR blueprint relies on science to inform policies, SciDev.Net reports

New hope for leukemia patients

IQWiG investigates benefits of rilpivirine for HIV treatment

International community should 'not forget' importance of treatment, care for children with HIV

Lancet editorial examines possibility of 'AIDS-free generation,' PEPFAR blueprint

GlobalPost blog interviews reporter Joanne Silberner about PRI series on cancer in developing world

Cost-benefit analysis of TasP compared with circumcision, ART

Boehner, Obama move to direct talks on budget

GlobalPost reports on HIV/AIDS in Latin America

Ultrasound applied to fingertips can stimulate sensory pathways leading to the brain

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News